Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 545841 - 545860 out of 553696 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FX29) talquetamab | TALVEY 40MG/ML INJ,SOLN | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX31) zolbetuximab | VYLOY 100MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Esophageal Neoplasms | AstellasPharmaU.S.,Inc. |
| USA | (L01FX31) zolbetuximab | VYLOY 300MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Esophageal Neoplasms | AstellasPharmaU.S.,Inc. |
| USA | (L01FX32) elranatamab | ELREXFIO 44MG/1.1ML INJ,SOLN | 1.1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 44MG/1.1ML INJ,SOLN | 1.1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 76MG/1.9ML INJ,SOLN | 1.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 76MG/1.9ML INJ,SOLN | 1.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX33) tarlatamab | IMDELLTRA 10MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSA,Inc. |
| USA | (L01FX33) tarlatamab | IMDELLTRA 10MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSA,Inc. |
| USA | (L01FX33) tarlatamab | IMDELLTRA 1MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSA,Inc. |
| USA | (L01FX33) tarlatamab | IMDELLTRA 1MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSA,Inc. |
| USA | (L01FX35) datopotamab deruxtecan | DATROWAY 100MG/VIAL INJ,LY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyo,Inc. |
| USA | (L01FX35) datopotamab deruxtecan | DATROWAY 100MG/VIAL INJ,LY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyo,Inc. |
| USA | (L01FY01) pertuzumab and trastuzumab | PHESGO | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FY01) pertuzumab and trastuzumab | PHESGO | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FY01) pertuzumab and trastuzumab | PHESGO | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FY01) pertuzumab and trastuzumab | PHESGO | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FY02) nivolumab and relatlimab | OPDUALAG 200MG/80MG INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbCompany |
| USA | (L01FY02) nivolumab and relatlimab | OPDUALAG 200MG/80MG INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbCompany |
| USA | (L01XA01) cisplatin | CISPLATIN 100MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
Pages
